|
| Patient | Non-compliance | Reason for non-compliance | Response |
| Compliant patients | 4 | Compliant |
| CR |
| 9 | Compliant |
| PR | |
| 10 | Compliant |
| CR | |
| 11 | Compliant |
| PR | |
| Non-compliant patients | 1 | No dasatinib | Infection | PR |
| 2 | Sirolimus instead of everolimus | Cost | SD | |
| 3 | Discontinued everolimus due to lack of insurance coverage | Cost | PD | |
| 5 | No dasatinib | Used lapatinib instead | PR | |
| 6 | No BVZ | No hypermetabolic lesion by PET scan | SD | |
| 7 | Interruption of BVZ | Cost | PD | |
| 8 | Interruption of all medications | Pancreatitis, pneumonia | SD |